Open Access
CC BY 4.0 · Endosc Int Open 2025; 13: a25420618
DOI: 10.1055/a-2542-0618
Original article

Implementing educational interventions and key performance measures sustains quality of endoscopic assessment in patients with Barrett’s esophagus

1   Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia (Ringgold ID: RIN60093)
2   Health Sciences and Medicine, Bond University Ltd, Gold Coast, Australia (Ringgold ID: RIN3555)
,
Pradeep Kakkadasam Ramaswamy
1   Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia (Ringgold ID: RIN60093)
,
Mark Jones
2   Health Sciences and Medicine, Bond University Ltd, Gold Coast, Australia (Ringgold ID: RIN3555)
,
Sneha John
1   Department of Digestive Health, Gold Coast University Hospital, Gold Coast, Australia (Ringgold ID: RIN60093)
2   Health Sciences and Medicine, Bond University Ltd, Gold Coast, Australia (Ringgold ID: RIN3555)
› Author Affiliations
Preview

Abstract

Background and study aims

Quality metrics for Barrett’s esophagus (BE) are anticipated to improve outcomes for patients through earlier detection of neoplasia. The European Society of Gastrointestinal Endoscopy has developed guidelines to homogenize endoscopic quality in BE. Our study aimed to assess the impact of recommended key performance measures (KPMs) and their sustainability.

Patients and methods

A single-center, retrospective study (Phase 1) was conducted over 8 weeks. The KPMs assessed were: 1) pre-procedure metrics including indication, consent, safety checklist (target of 100%); and 2) Prague classification, Seattle protocol, or targeted biopsies, inspection time of 1 minute per cm, advanced imaging and surveillance recommendations (target of 90%). Following baseline analysis, multimodal educational interventions were implemented and repeated at 6-month intervals. Repeat analysis was performed at 6 months and 1 and 3 years (Phases 2, 3 and 4 respectively).

Results

In Phase 1, 39 patients with BE underwent endoscopy. Phase 2 evaluated 40 patients with BE. Phase 3 analyzed 59 patients with BE, and Phase 4 identified 34 patients with BE. Pre-procedure metrics were met in 100% of patients across the 3-year period. Baseline analysis displayed suboptimal performance at 45% to 75% for all other KPMs. However, after regular multimodal educational interventions, quality standards significantly improved and were able to be maintained over all phases, achieving pre-set targets of >9 0% for all KPMs except one.

Conclusions

Sustaining improvements in quality metrics in Barrett’s endoscopy is important. Our study suggests that regular, replicable education interventions have a positive effect and allow sustained long-term improvements in quality metrics.



Publication History

Received: 22 July 2024

Accepted after revision: 03 February 2025

Article published online:
14 March 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Deloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Mark Jones, Sneha John. Implementing educational interventions and key performance measures sustains quality of endoscopic assessment in patients with Barrett’s esophagus. Endosc Int Open 2025; 13: a25420618.
DOI: 10.1055/a-2542-0618
 
  • References

  • 1 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s esophagus. Gut 2014; 63: 7-42
  • 2 Shaheen NJ, Falk GW, Iyer PG. et al. Diagnosis and management of Barrett’s esophagus: An updated ACG guideline. Am J Gastroenterol 2022; 117: 559-587
  • 3 Wani S, Falk GW, Post J. et al. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology 2011; 141: 1179-1186
  • 4 Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol 2021; 18: 432-443
  • 5 Sharma P, Katzka DA, Gupta N. et al. Quality indicators for the management of Barrett’s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology 2015; 149: 1599-1606
  • 6 Shaheen NJ, Overholt BF, Sampliner RE. et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 2011; 141: 460-468
  • 7 Weusten B, Bisschops R, Dinis-Riberiro M. et al. Diagnosis and management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2023; 55: 1124-1146
  • 8 Farina DA, Beveridge CA, Kia L. et al. Adherence to quality indicators for diagnosis and surveillance of Barrett’s esophagus: a comparative study of Barrett’s experts and nonexperts. Tech Innov Gastrointest Endosc 2023; 25: 204-212
  • 9 Imperiali G, Minoli G, Meucci GM. et al. Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy 2007; 39: 314-318
  • 10 Enke T, Keswani R, Triggs J. et al. Adherence to quality indicators and best practices in surveillance endoscopy of Barrett’s esophagus: a video-based assessment. Endosc Int Open 2024; 12: E90-E96
  • 11 Sharma P, Dent J, Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
  • 12 Everson MA, Ragunath K, Bhandari P. et al. How to perform a high-quality examination in patients with Barrett’s esophagus. Gastroenterology 2018; 154: 1222-1226
  • 13 Gupta N, Gaddam S, Wani SB. et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 2012; 76: 531-538
  • 14 Coletta M, Sami SS, Nachiappan A. et al. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Gastrointest Endosc 2016; 83: 57-67.e1
  • 15 Fitzgerald RC, Saeed IT, Khoo D. et al. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. Dig Dis Sci 2001; 46: 1892-1898
  • 16 Reid BJ, Blount PL, Feng Z. et al. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089-3096
  • 17 Whiteman DC, Appleyard M, Bahin FF. et al. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 2015; 30: 804-820
  • 18 Westerveld D, Khullar V, Mramba L. et al. Adherence to quality indicators and surveillance guidelines in the management of Barrett’s oesophagus: a retrospective analysis. Endosc Int Open 2018; 6: E300-E307
  • 19 Abrams JA, Kapel RC, Lindberg GM. et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009; 7: 736-742
  • 20 Menezes A, Tierney A, Yang YX. et al. Adherence to the 2011 American Gastroenterological Association medical position statement for the diagnosis and management of Barrett’s esophagus. Dis Esophagus 2015; 28: 538-546
  • 21 Yang LS, Thompson AJ, Taylor ACF. et al. Quality of upper GI endoscopy: a prospective cohort study on impact of endoscopist education. Gastrointest Endosc 2022; 96: 467-475
  • 22 Cordova H, Sanchez-Montes C, Delgado-Guillena PG. et al. Quality indicators for oesophagogastroduodenoscopy: a comparative study of outcomes after an improvement programme in a tertiary hospital. Gastroenterol Hepatol 2017; 40: 587-594
  • 23 Ooi J, Wilson P, Walker G. et al. Dedicated Barrett’s surveillance sessions managed by trained endoscopists improve dysplasia detection rate. Endoscopy 2017; 49: 524-528
  • 24 Parasa S, Wallace MB, Srinivasan S. et al. Educational intervention to improve quality of care in Barrett’s esophagus: the AQUIRE randomized controlled trial. Gastrointest Endosc 2022; 95: 239-245